Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

36

Revenue 2017

Xtandi

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Xtandi was produced by Astellas.

NICE backtracks on prostate cancer drug enzalutamide

NICE backtracks on prostate cancer drug enzalutamide Says Astellas and Medivation's Xtandi can be used within the NHS in England and Wales. ... Xtandi was approved in Europe last year and is predicted to make sales of more than $500m this year, mainly on the back of strong growth in the US.

Xtandi on course for pre-chemo use in prostate cancer

Xtandi on course for pre-chemo use in prostate cancer Medivation is also trying to position Xtandi earlier in the course of prostate cancer, as well as in other indications such as breast cancer. ... Medivation also has two phase II trials comparing Xtandi with Casodex, the most widely-used anti-androgen.

NICE gives partial backing to Ferring's prostate cancer drug

NICE gives partial backing to Ferring's prostate cancer drug Prostate Cancer UK is in the midst of a battle with NICE to try to convince the agency to reverse its decision to impose tight restrictions on prescribing of Astellas' Xtandi

Otsuka's Samsca heads clutch of Japanese approvals

Astellas' Xtandi, AstraZeneca's Forxiga and Takeda's Zacras also given the green light. ... Astellas and Medivation's oral androgen receptor inhibitor Xtandi (enzalutamide) for the treatment of patients with castration-resistant prostate cancer (CRPC).

Xtandi filed as pre-chemo prostate cancer therapy

Xtandi filed as pre-chemo prostate cancer therapy data monitoring committee recommended that it be stopped early and all patients offered Xtandi. ... Medivation shares Xtandi sales and profits with Astellas in the US, while the latter books all revenue from the product outside the US and pays Medivation

[ Previous 5 results ] 9 10 11 12 13 14 15 16 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics